Standard
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland : Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting. / Botvid, Sofia H.C.; Hove, Lone Storgaard; Bouazzi, Dorra; Andersen, Rune Kjærsgaard; Thomsen, Simon Francis; Saunte, Ditte Marie; Jemec, Gregor B.E.
I:
Acta Dermato-Venereologica, Bind 103, adv00847, 2023.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Botvid, SHC, Hove, LS, Bouazzi, D
, Andersen, RK, Thomsen, SF, Saunte, DM & Jemec, GBE 2023, '
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting',
Acta Dermato-Venereologica, bind 103, adv00847.
https://doi.org/10.2340/actadv.v103.4410APA
Botvid, S. H. C., Hove, L. S., Bouazzi, D.
, Andersen, R. K., Thomsen, S. F., Saunte, D. M., & Jemec, G. B. E. (2023).
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting.
Acta Dermato-Venereologica,
103, [adv00847].
https://doi.org/10.2340/actadv.v103.4410Vancouver
Botvid SHC, Hove LS, Bouazzi D
, Andersen RK, Thomsen SF, Saunte DM o.a.
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting.
Acta Dermato-Venereologica. 2023;103. adv00847.
https://doi.org/10.2340/actadv.v103.4410Author
Botvid, Sofia H.C. ; Hove, Lone Storgaard ; Bouazzi, Dorra ; Andersen, Rune Kjærsgaard ; Thomsen, Simon Francis ; Saunte, Ditte Marie ; Jemec, Gregor B.E. / Hidradenitis Suppurativa Prevalence in Nuuk, Greenland : Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting. I: Acta Dermato-Venereologica. 2023 ; Bind 103.
Bibtex
@article{3d9b150cef8f4bc694e6e41c980d6ce7,
title = "Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting",
author = "Botvid, {Sofia H.C.} and Hove, {Lone Storgaard} and Dorra Bouazzi and Andersen, {Rune Kj{\ae}rsgaard} and Thomsen, {Simon Francis} and Saunte, {Ditte Marie} and Jemec, {Gregor B.E.}",
note = "Funding Information: The study was supported by the Greenlandic Research Foundation for Medical Doctors in Greenland. We would especially like to thank our Greenlandic colleagues Aviannguaq Kreutzmann and Trine Pedersen Abelsen for their indispensable contribution to this study. This study could not have been conducted without their translations and knowledge of the Greenlandic Inuit language. We would also like to thank all the patients, who let us examine them and take clinical photographs of their skin conditions. Conflicts of interest: DB: UCB Nordic has paid for EADV congress participation. RKA: Eli Lilly has paid for NCDV 2022 congress participation. SFT has been a speaker or advisor for Sanofi, AbbVie, LEO Pharma, Pfizer, Eli Lilly, Novartis, UCB Pharma, Almirall, Union Therapeutics, and Janssen Pharmaceuticals; and has received research support from Sanofi, AbbVie, LEO Pharma, Novartis, UCB Pharma, and Janssen Pharmaceuticals, outside the submitted work. DMS received honoraria as a consultant for advisory board meetings by AbbVie, Janssen, Sanofi, LeoPharma and as a speaker and/or received grants from the following companies: Abbvie, Janssen, Novartis, Sanofi and Leo Pharma during the last 3 years. GBEJ has received research funding and/or honoraria from Abbvie, InflRx, Janssen-Cilag, Leo Pharma, Novartis, ChemoCentryx, Regeneron and Serono. The other authors have no conflicts of interest to declare.",
year = "2023",
doi = "10.2340/actadv.v103.4410",
language = "English",
volume = "103",
journal = "Acta Dermato-Venereologica",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato - Venereologica",
}
RIS
TY - JOUR
T1 - Hidradenitis Suppurativa Prevalence in Nuuk, Greenland
T2 - Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
AU - Botvid, Sofia H.C.
AU - Hove, Lone Storgaard
AU - Bouazzi, Dorra
AU - Andersen, Rune Kjærsgaard
AU - Thomsen, Simon Francis
AU - Saunte, Ditte Marie
AU - Jemec, Gregor B.E.
N1 - Funding Information:
The study was supported by the Greenlandic Research Foundation for Medical Doctors in Greenland. We would especially like to thank our Greenlandic colleagues Aviannguaq Kreutzmann and Trine Pedersen Abelsen for their indispensable contribution to this study. This study could not have been conducted without their translations and knowledge of the Greenlandic Inuit language. We would also like to thank all the patients, who let us examine them and take clinical photographs of their skin conditions. Conflicts of interest: DB: UCB Nordic has paid for EADV congress participation. RKA: Eli Lilly has paid for NCDV 2022 congress participation. SFT has been a speaker or advisor for Sanofi, AbbVie, LEO Pharma, Pfizer, Eli Lilly, Novartis, UCB Pharma, Almirall, Union Therapeutics, and Janssen Pharmaceuticals; and has received research support from Sanofi, AbbVie, LEO Pharma, Novartis, UCB Pharma, and Janssen Pharmaceuticals, outside the submitted work. DMS received honoraria as a consultant for advisory board meetings by AbbVie, Janssen, Sanofi, LeoPharma and as a speaker and/or received grants from the following companies: Abbvie, Janssen, Novartis, Sanofi and Leo Pharma during the last 3 years. GBEJ has received research funding and/or honoraria from Abbvie, InflRx, Janssen-Cilag, Leo Pharma, Novartis, ChemoCentryx, Regeneron and Serono. The other authors have no conflicts of interest to declare.
PY - 2023
Y1 - 2023
U2 - 10.2340/actadv.v103.4410
DO - 10.2340/actadv.v103.4410
M3 - Journal article
C2 - 36625210
AN - SCOPUS:85145957209
VL - 103
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
SN - 0001-5555
M1 - adv00847
ER -
